Immortalized avian cell lines and use thereof
AssigneeTransgene S.A.
InventorsJean-Marc Balloul, Marina Kapfer, Thierry Menguy
Life of this patent
Estimating the term…
Loading patent…
AssigneeTransgene S.A.
InventorsJean-Marc Balloul, Marina Kapfer, Thierry Menguy
Estimating the term…
The present invention relates to specific immortalized avian cell lines expressing telomerase reverse transcriptase (TERT), and exhibiting distinct biologics production patterns. More particularly, the present invention relates to immortalized avian cell line capable of either amplifying Flaviviridae but not capable of amplifying Vaccinia virus strain Copenhagen (VV-COP) nor Modified Vaccinia virus Ankara (MVA), or capable of amplifying both Flaviviridae and Poxviridae. The invention further relates to the use of said immortalized avian cell lines and related methods for producing biologics, including viruses and proteins.
-24. (canceled)
Use of the immortalized avian cell line deposited at the European Collection of Cell Cultures (ECACC) under accession number 08060502 and derivatives thereof, for the production of viruses and proteins.
Use of the immortalized avian cell line deposited at the European Collection of Cell Cultures (ECACC) under accession number 08060501 and derivatives thereof, for the production of viruses and proteins.
A method for producing a protein comprising the steps of:
A method for producing a protein comprising the steps of:
Dependencies are inferred from the claim text.